Tag: Dr. Robert Pierce
Lupin spins out two onco programs to Kaveri TherapeuticsÂ
Global pharmaceutical leader Lupin Limited has announced the strategic spin-out of two oncology programs – LNP7457 (PRMT5) and LNP8701 (SOS1), through its wholly owned...
